Accelerated MEN2A in homozygous RET carriers in the context of consanguinity
European Journal of Endocrinology · 2024
DOI: 10.1093/ejendo/lvae025 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Endocrinology, 2024. Verfasst von Andreas Machens und 1 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty, Department of Visceral, Vascular and Endocrine Surgery, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, D-06097 Hall…. Hauptthemen laut MEDLINE: Multiple Endocrine Neoplasia Type 2a, Pheochromocytoma, Thyroid Neoplasms, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Background
Homozygous mutations, 2 identical gene versions (alleles), 1 from each biological parent, are exceptional. Clinical descriptions of affected families, comprising few carriers only, are scattered throughout the literature, hindering evidence generation.
Methods
Included in this literature analysis were 5 RET families with ≥1 homozygous carrier and ≥3 heterozygous carriers per family.
Results
In consanguineous families with first-degree cousins, homozygotes presented with node-positive medullary thyroid cancer and pheochromocytoma in their mid-teens, whereas heterozygotes presented in their end-30s and early 40s. Homozygotes developed node-positive medullary thyroid cancer 27.4 years and pheochromocytoma 23 years earlier than heterozygotes. These age differences were smaller in the 15 families carrying founder mutation p.Leu666delinsAsnSer, whereas homozygotes developed node-positive medullary thyroid cancer in their mid-40s, 6 years earlier than heterozygotes in their early 50s.
Conclusion
These results, limited in scope and size and modulated by extent of consanguinity, are consistent with moderate dose–response effects accelerating MEN2A development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Faculty, Department of Visceral, Vascular and Endocrine Surgery, Martin Luther University Halle-Wittenberg, Ernst-Grube-Str. 40, D-06097 Halle (Saale), Germany.
- Department of General, Visceral and Transplantation Surgery, Division of Endocrine Surgery, University of Duisburg-Essen, D-45122 Essen, Germany.
ORCID-Profile: Andreas Machens
Zitieren
APA
Machens, A., & Dralle, H. (2024). Accelerated MEN2A in homozygous RET carriers in the context of consanguinity. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvae025
Vancouver
Machens A, Dralle H. Accelerated MEN2A in homozygous RET carriers in the context of consanguinity. European Journal of Endocrinology. 2024. doi:10.1093/ejendo/lvae025
BibTeX
@article{Machens2024,
author = {Machens, Andreas and Dralle, Henning},
title = {Accelerated MEN2A in homozygous RET carriers in the context of consanguinity},
journal = {European Journal of Endocrinology},
year = {2024},
doi = {10.1093/ejendo/lvae025}
}
EUVIMED